Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 82

Results For "India"

3569 News Found

Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4
News | July 04, 2021

Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4

The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021


India aims to vaccinate 1 crore people every day
News | June 12, 2021

India aims to vaccinate 1 crore people every day

India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021


Sun Pharma and Ferring Pharmaceuticals to introducing CARITEC in India
News | June 03, 2021

Sun Pharma and Ferring Pharmaceuticals to introducing CARITEC in India

Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC


Unilever to launch recyclable tubes for oral care in India
Packaging | June 01, 2021

Unilever to launch recyclable tubes for oral care in India

EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever


TLC partners Strides to launch Mucormycosis drug in India
News | May 28, 2021

TLC partners Strides to launch Mucormycosis drug in India

Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides


Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
News | May 26, 2021

Zydus and TLC sign agreement to market Liposomal Amphotericin B in India

With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage


Cipla to market Roche's Antibody Cocktail in India
Policy | May 25, 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19


Bal Pharma launches BALflu, Favipiravir formulation in India
News | May 25, 2021

Bal Pharma launches BALflu, Favipiravir formulation in India

BALflu is approved by DCGI for emergency use for the treatment of COVID-19


Astrazeneca Pharma India Q4FY21 net profit up at Rs 27.27 Cr
News | May 25, 2021

Astrazeneca Pharma India Q4FY21 net profit up at Rs 27.27 Cr

The company has reported total income of Rs.826.40 crores for FY 2020-21


India's first indigenous COVID-19 RT-PCR testing kit approved
News | May 21, 2021

India's first indigenous COVID-19 RT-PCR testing kit approved

This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips